China’s high-value invention patents reach 17.2 per 10,000 people

The significance here is less the headline patent density than where the filings are concentrated: quantum, biomanufacturing, brain-computer interfaces and 6G are all frontier fields where patent portfolios shape standard-setting and licensing leverage well before commercial products exist. For RWA and tokenization markets, the read-through is indirect but real, since IP is increasingly discussed as a candidate asset class for on-chain claims, and a deeper domestic patent pool changes the potential collateral base. Whether deployment in these future industries translates into enforceable, licensable assets rather than defensive filings is the open question worth watching.